LATEST

• BUSINESS LEO Pharma Begins Promotional Activities for Spevigo in Japan
  October 6, 2025

• BUSINESS Sanofi Files ITP Drug Rilzabrutinib in Japan
  October 6, 2025

• BUSINESS Moderna Reaffirms Japan Commitment, Denies Downsizing Concerns
  October 3, 2025

• BUSINESS Regeneron Bolsters Japan Oncology Team as Libtayo Gains Ground
  October 3, 2025

• BUSINESS Argenx Puts Japan at Core of Global Innovation Strategy
  October 3, 2025

• REGULATORY Panel Split on Delisting OTC-Like Drugs from Insurance Coverage
  October 3, 2025

• BUSINESS Daiichi Sankyo Opens Third Overseas Research Hub in San Diego
  October 3, 2025

• BUSINESS Enhertu Accepted for US Review in Pre-Surgery Setting for Early Breast Cancer
  October 3, 2025

• BUSINESS Ziftomenib Given in New AML Cohort in US PI Trial: Kura/Kyowa Kirin
  October 3, 2025

• BUSINESS HIV Support Groups Call for Stronger Mail-In Testing System in Japan
  October 3, 2025

• REGULATORY SanBio’s Akuugo Set for Re-Review on Oct. 16, Shipment Decision Nears
  October 3, 2025

• BUSINESS Dayvigo, Jardiance Keep Up Strong Promotion in August: Intage
  October 3, 2025

• BUSINESS AbbVie Aims for Neuroscience Leadership, CSO Says in Tokyo
  October 2, 2025

• ORGANIZATION Think Tanks Urge Unique Value Framework for Regenerative Medicine in 2026 Reform
  October 2, 2025

• BUSINESS Kyorin Bags Japan Rights to Hinge Bio’s SLE Med
  October 2, 2025

• BUSINESS JCR Out-Licenses Fabry Drug to Oman’s Menagen for MENAT Region
  October 2, 2025

• BUSINESS Specialist Urges More COVID Shots for Elderly amid “13th Wave”
  October 2, 2025

• BUSINESS Sanofi Sets Sights on 2026 NIP Inclusion of RSV Drug Beyfortus in Japan
  October 2, 2025

• BUSINESS Teijin, Australian CDMO Form Alliance for Cell and Gene Therapies in Asia-Pacific
  October 2, 2025

• BUSINESS Fuji Pharma Seeks Dysmenorrhea Use for Nextstellis in Thailand
  October 2, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• …
• Next ›
• 最終 »